2. Immunology/Inflammation NF-κB Metabolic Enzyme/Protease
  3. Reactive Oxygen Species (ROS)
  4. Mitoflaxone

Mitoflaxone (flavoneacetic acid) is a synthetic flavonoid compound with vascular targeting properties. Mitoflaxone exerts anti-proliferative effects on endothelial cells through a superoxide-dependent mechanism, this effect leads to changes in the permeability of tumor blood vessels, thereby exerting anti-tumor effects[1][2].

For research use only. We do not sell to patients.

Mitoflaxone

Mitoflaxone Chemical Structure

CAS No. : 87626-55-9

Size Stock
50 mg   Get quote  
100 mg   Get quote  
250 mg   Get quote  

* Please select Quantity before adding items.

This product is a controlled substance and not for sale in your territory.

Mitoflaxone Related Antibodies

Top Publications Citing Use of Products

  • Biological Activity

  • Purity & Documentation

  • References

  • Customer Review

Description

Mitoflaxone (flavoneacetic acid) is a synthetic flavonoid compound with vascular targeting properties. Mitoflaxone exerts anti-proliferative effects on endothelial cells through a superoxide-dependent mechanism, this effect leads to changes in the permeability of tumor blood vessels, thereby exerting anti-tumor effects[1][2].

Cellular Effect
Cell Line Type Value Description References
2008 IC50
421.3 μM
Compound: FAA (Flavone -8-acetic acid)
Direct cytotoxicity against the selected tumor cell line 2008 was determined especially on ovarian adenocarcinoma derived cells
Direct cytotoxicity against the selected tumor cell line 2008 was determined especially on ovarian adenocarcinoma derived cells
[PMID: 12904070]
A549 IC50
341.5 μM
Compound: 2, FAA
Cytotoxicity against human A549 cells after 24 hrs by MTT assay
Cytotoxicity against human A549 cells after 24 hrs by MTT assay
[PMID: 24518295]
C13 IC50
233.3 μM
Compound: FAA (Flavone -8-acetic acid)
Direct cytotoxicity against the selected tumor cell line c13* was determined especially on ovarian adenocarcinoma derived cells
Direct cytotoxicity against the selected tumor cell line c13* was determined especially on ovarian adenocarcinoma derived cells
[PMID: 12904070]
DLD-1 IC50
> 500 μg/mL
Compound: 1 (FAA, NSC-347512 LM975)
In vitro concentration required to inhibit DLD1 cells
In vitro concentration required to inhibit DLD1 cells
10.1016/0960-894X(94)85031-3
HCT-8 IC50
245 μg/mL
Compound: 1 (FAA, NSC-347512 LM975)
In vitro concentration required to inhibit HCT18 cells
In vitro concentration required to inhibit HCT18 cells
10.1016/0960-894X(94)85031-3
HT-29 IC50
2449.5 μM
Compound: 2, FAA
Cytotoxicity against human HT-29 cells after 24 hrs by MTT assay
Cytotoxicity against human HT-29 cells after 24 hrs by MTT assay
[PMID: 24518295]
HT-29 IC50
390 μg/mL
Compound: 1 (FAA, NSC-347512 LM975)
In vitro concentration required to inhibit HT-29 cells
In vitro concentration required to inhibit HT-29 cells
10.1016/0960-894X(94)85031-3
K562 IC50
310 μg/mL
Compound: 1 (FAA, NSC-347512 LM975)
In vitro concentration required to inhibit K562 cells
In vitro concentration required to inhibit K562 cells
10.1016/0960-894X(94)85031-3
LoVo IC50
378.3 μM
Compound: FAA (Flavone -8-acetic acid)
In vitro cytotoxicity against the selected tumor cell line LoVoR arising from human colon adenocarcinoma was determined
In vitro cytotoxicity against the selected tumor cell line LoVoR arising from human colon adenocarcinoma was determined
[PMID: 12904070]
LoVo IC50
563.9 μM
Compound: FAA (Flavone -8-acetic acid)
In vitro cytotoxicity against the selected tumor cell line LoVoS arising from human colon adenocarcinoma was determined
In vitro cytotoxicity against the selected tumor cell line LoVoS arising from human colon adenocarcinoma was determined
[PMID: 12904070]
MAC15A IC50
150 μg/mL
Compound: 1 (FAA, NSC-347512 LM975)
In vitro concentration required to inhibit MAC 15 A cells
In vitro concentration required to inhibit MAC 15 A cells
10.1016/0960-894X(94)85031-3
MAC16 IC50
180 μg/mL
Compound: 1 (FAA, NSC-347512 LM975)
In vitro concentration required to inhibit MAC 16 cells
In vitro concentration required to inhibit MAC 16 cells
10.1016/0960-894X(94)85031-3
MAC26 IC50
208 μg/mL
Compound: 1 (FAA, NSC-347512 LM975)
In vitro concentration required to inhibit MAC 26 cells
In vitro concentration required to inhibit MAC 26 cells
10.1016/0960-894X(94)85031-3
Molecular Weight

280.27

Formula

C17H12O4
CAS No.
SMILES

O=C1C2=C(C(CC(O)=O)=CC=C2)OC(C3=CC=CC=C3)=C1
Shipping

Room temperature in continental US; may vary elsewhere.
Storage

Please store the product under the recommended conditions in the Certificate of Analysis.
Purity & Documentation
References
  • No file chosen (Maximum size is: 1024 Kb)
  • If you have published this work, please enter the PubMed ID.
  • Your name will appear on the site.

Mitoflaxone Related Classifications

  • Molarity Calculator

  • Dilution Calculator

The molarity calculator equation

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

Mass   Concentration   Volume   Molecular Weight *
= × ×

The dilution calculator equation

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
× = ×
C1   V1   C2   V2
Help & FAQs
  • Do most proteins show cross-species activity?

    Species cross-reactivity must be investigated individually for each product. Many human cytokines will produce a nice response in mouse cell lines, and many mouse proteins will show activity on human cells. Other proteins may have a lower specific activity when used in the opposite species.

Keywords:

Mitoflaxone87626-55-9Flavoneacetic acidReactive Oxygen Species (ROS)flavoneacetic acidantineoplastic drugflavonoidanticancer agentvascular targetingimmune modulationclinical developmentstructure-activity relationshipcombination therapyInhibitorinhibitorinhibit

Your Recently Viewed Products:

Inquiry Online

Your information is safe with us. * Required Fields.

Product Name

  

Requested Quantity *

Applicant Name *

 

Salutation

Email Address *

 

Phone Number *

Department

 

Organization Name *

City

State

Country or Region *

      

Remarks

Bulk Inquiry

Inquiry Information

Product Name:
Mitoflaxone
Cat. No.:
HY-119340
Quantity:
MCE Japan Authorized Agent:

Customer Review

Thank You for Your Feedback!

Request for HNMR Report

Please fill out this form to request the QC report. We will send it to your Email address shortly.

Your information is safe with us. * Required Fields.

Product Name

  

Lot #

Applicant Name *

 

Email Address *

Phone Number

 

Department *

Organization Name *

 

Country or Region *

Remarks

SAFETY DATA SHEET (SDS)

Request for HNMR Report

We have received your request and will respond to you as soon as possible.